ClearBridge Energy MLP Opportunity Fund Inc. is a non-diversified, closed-end management investment company. The company has market cap of $414.28 million. The Fund’s investment objective is to provide long-term investors a high level of total return with an emphasis on cash distributions. It currently has negative earnings. The Fund seeks to achieve its objective by investing primarily in master limited partnerships (MLPs) in the energy sector.
The stock of Quest Diagnostics Inc (NYSE:DGX) hit a new 52-week high and has $110.99 target or 7.00% above today’s $103.73 share price. The 7 months bullish chart indicates low risk for the $14.37 billion company. The 1-year high was reported on Apr, 20 by Barchart.com. If the $110.99 price target is reached, the company will be worth $1.01 billion more. About 2.81 million shares traded or 279.35% up from the average. Quest Diagnostics Inc (NYSE:DGX) has risen 19.20% since September 13, 2016 and is uptrending. It has outperformed by 9.27% the S&P500.
Since November 15, 2016, it had 0 insider buys, and 10 sales for $18.08 million activity. Shares for $112,512 were sold by PREVOZNIK MICHAEL E on Monday, February 13. PFEIFFER GARY M sold $3.63M worth of Quest Diagnostics Inc (NYSE:DGX) on Tuesday, November 15. Doherty Catherine T. also sold $703,908 worth of Quest Diagnostics Inc (NYSE:DGX) on Thursday, March 2. $191,016 worth of Quest Diagnostics Inc (NYSE:DGX) was sold by ZIEGLER JOHN B.
Quest Diagnostics Incorporated is a well-known provider of diagnostic information services. The company has market cap of $14.37 billion. The Firm operates through two businesses: Diagnostic Information Services and Diagnostic Solutions. It has a 22.84 P/E ratio. The Diagnostic Information Services business develops and delivers diagnostic testing information and services, providing insights that empower and enable a range of customers, including patients, clinicians, hospitals, integrated delivery networks , health plans, employers and accountable care organizations (ACOs).
Among 12 analysts covering Quest Diagnostics (NYSE:DGX), 6 have Buy rating, 1 Sell and 5 Hold. Therefore 50% are positive. Quest Diagnostics had 21 analyst reports since August 4, 2015 according to SRatingsIntel. The firm has “Sell” rating given on Friday, June 24 by Jyske Bank. Citigroup initiated the shares of DGX in report on Friday, September 9 with “Neutral” rating. The company was maintained on Friday, November 13 by Canaccord Genuity. The stock of Quest Diagnostics Inc (NYSE:DGX) has “Neutral” rating given on Wednesday, August 31 by Mizuho. The rating was maintained by Mizuho on Friday, October 21 with “Neutral”. On Friday, October 23 the stock rating was maintained by RBC Capital Markets with “Sector Perform”. Zacks upgraded the stock to “Hold” rating in Tuesday, August 18 report. Wells Fargo upgraded the stock to “Market Perform” rating in Friday, October 16 report. The rating was upgraded by Goldman Sachs to “Buy” on Monday, December 12. The firm earned “Sector Perform” rating on Friday, January 29 by RBC Capital Markets.
Investors sentiment increased to 1.1 in 2016 Q4. Its up 0.18, from 0.92 in 2016Q3. It increased, as 41 investors sold Quest Diagnostics Inc shares while 179 reduced holdings. 79 funds opened positions while 163 raised stakes. 117.50 million shares or 0.59% more from 116.81 million shares in 2016Q3 were reported. Silvercrest Asset Gp Ltd Liability has 2,422 shares. Coldstream Mgmt Incorporated stated it has 5,520 shares or 0.08% of all its holdings. Mufg Americas owns 20,534 shares. Panagora Asset Mgmt holds 0.01% in Quest Diagnostics Inc (NYSE:DGX) or 13,978 shares. Tompkins Financial Corporation holds 0.02% or 722 shares. First Wilshire Securities Mngmt Inc owns 2,450 shares. Old Second National Bank & Trust Of Aurora holds 0.02% or 500 shares. Mountain Pacific Invest Advisers Id accumulated 0.04% or 4,050 shares. New York-based Neuberger Berman Grp Limited Liability Com has invested 0% in Quest Diagnostics Inc (NYSE:DGX). Brick Kyle Assoc invested 0.03% of its portfolio in Quest Diagnostics Inc (NYSE:DGX). Healthcor Management Limited Partnership accumulated 1.13M shares. Pinnacle Associate Limited holds 0.05% of its portfolio in Quest Diagnostics Inc (NYSE:DGX) for 24,381 shares. Stifel Financial reported 56,346 shares. Wedge Capital Mgmt L Lp Nc reported 0.01% stake. Rhumbline Advisers holds 335,665 shares or 0.08% of its portfolio.
